Wednesday, February 7, 2018

Cannabinoids and Prostate Cancer



Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest*
http://www.jbc.org/content/281/51/39480.full.pdf

Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer
http://cancerres.aacrjournals.org/content/canres/65/5/1635.full.pdf

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R( รพ )-Methanandamide and JWH-015: Involvement of CB2
https://www.nature.com/articles/6605248.pdf

Non-THC cannabinoids
inhibit prostate carcinoma
growth in vitro and in vivo:
pro-apoptotic effects and
underlying mechanisms
Non-THC cannabinoids
inhibit prostate carcinoma
growth in vitro and in vivo:
pro-apoptotic effects and
underlying mechanisms
Non THC Cannabinoids Inhibit Prostate Carcinomas
on-THC cannabinoids
inhibit prostate carcinoma
growth in vitro and in vivo:
pro-apoptotic effects and
underlying mechanisms
http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/epdf

Proapoptotic effect of endocannabinoids in prostate cancer cells
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358087/pdf/or-33-04-1599.pdf

The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications